NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/10/2025
Back to search
Official data from USPTO
VESALIUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
06/10/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
10/01/2021
Registration date
06/10/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/10/2025
Last transaction
06/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/10/2024
First use in commerce
12/10/2024
Drawing code
4
Owner type
03
Owner location
CAMBRIDGE, MA, US
Examiner
KEAM, ALEX S
Law office
O60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VESALIUS THERAPEUTICS INC.
Serqet Therapeutics, Inc.
Representatives
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and therapeutic pharmaceuticalsboth for the treatment of neurological diseases and disorderscentral nervous system diseases and disordersneurodegenerative diseases and disordersimmune system-related diseases and disordersmetabolic diseases and disorders
Class 42
Research and development of pharmaceutical preparations and therapeutic pharmaceuticalsboth for the treatment of neurological diseases and disorderscentral nervous system diseases and disordersneurodegenerative diseases and disordersimmune system-related diseases and disordersmetabolic diseases and disorders; pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/20/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/20/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/20/2025
IUAF
USE AMENDMENT FILED
03/27/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/27/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX4G
SOU EXTENSION 4 GRANTED
11/20/2024
EXT4
SOU EXTENSION 4 FILED
11/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
11/20/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/21/2024
EX3G
SOU EXTENSION 3 GRANTED
05/20/2024
EXT3
SOU EXTENSION 3 FILED
05/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/20/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/18/2023
EX2G
SOU EXTENSION 2 GRANTED
11/16/2023
EXT2
SOU EXTENSION 2 FILED
11/16/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/16/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/19/2023
EX1G
SOU EXTENSION 1 GRANTED
05/17/2023
EXT1
SOU EXTENSION 1 FILED
05/17/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/17/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/27/2022
PUBO
PUBLISHED FOR OPPOSITION
09/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/17/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/17/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/07/2022
GNRT
NON-FINAL ACTION E-MAILED
07/07/2022
CNRT
NON-FINAL ACTION WRITTEN
07/07/2022
DOCK
ASSIGNED TO EXAMINER
07/05/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2021
Continuous trademark protection
Get notified about every new filing that threatens VESALIUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.